A Schedule 13G was
Filed with the SEC on · accession 0001172661-26-003341
ATTO filed a SCHEDULE 13G (schedule 13g) with the SEC on Aug 12, 2026. A Schedule 13G was filed regarding Attovia Therapeutics, Inc. (ATTO), indicating a passive ownership position by a reporting holder. The stock moved -3.2% by the first close after the filing.
A Schedule 13G was filed regarding Attovia Therapeutics, Inc. (ATTO), indicating a passive ownership position by a reporting holder. The filing text provided contains only the EDGAR directory listing and no substantive ownership details.
Close before
$18.65
Aug 11, 2026
First close after
-3.16%
$18.06
5 trading days
+24.61%
$23.24
Since filing
-18.12%
$15.27
✦ Ask GOAX AI about this filing — what it means for ATTO, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for ATTO?
Click hereATTO filed a SCHEDULE 13G (SEC filing). A Schedule 13G was filed regarding Attovia Therapeutics, Inc. (ATTO), indicating a passive ownership position by a reporting holder. The filing text provided contains only the EDGAR directory listing and no substantive ownership details.
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G (schedule 13g): A report the company filed with the SEC (the US market regulator).
ATTO closed at $18.65 before the filing and $18.06 on Aug 12, 2026 (-3.16%). Five trading days later: $23.24 (+24.61%).
Get alerts when ATTO files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days